Updated on 2024/03/19

写真a

 
NISHIWAKI Satoshi
 
Organization
Nagoya University Hospital Lecturer
Graduate School
Graduate School of Medicine
Title
Lecturer

Degree 1

  1. 博士(医学) ( 2012.3   名古屋大学 ) 

Education 2

  1. Nagoya University   Graduate School, Division of Medical Sciences

    2009.4 - 2012

      More details

    Country: Japan

  2. Nagoya University   Faculty of Medicine

    1998.4 - 2004

      More details

    Country: Japan

Awards 5

  1. 日本白血病研究基金若手奨励研究賞

    2015.11   日本白血病研究基金  

     More details

    Award type:Award from publisher, newspaper, foundation, etc.  Country:Japan

  2. 2012 ASCO Annual Meeting Merit Award

    2012.6   American Society of Clinical Oncology  

     More details

    Award type:Award from international society, conference, symposium, etc.  Country:United States

  3. 名古屋大学学術奨励賞

    2011.7   名古屋大学  

     More details

    Country:Japan

  4. 日本白血病研究基金一般研究賞(日本臨床血液学会推薦)

    2008.11   日本白血病研究基金  

     More details

    Award type:Award from publisher, newspaper, foundation, etc.  Country:Japan

  5. 日本造血細胞移植学会奨励賞

    2008.2   日本造血細胞移植学会  

     More details

    Award type:Award from Japanese society, conference, symposium, etc.  Country:Japan

 

Papers 70

  1. Reduced-intensity allogenic transplantation for children and adolescents with Philadelphia chromosome-positive acute lymphoblastic leukemia

    Ishida, H; Arakawa, Y; Hasegawa, D; Usami, I; Hashii, Y; Arai, Y; Nishiwaki, S; Keino, D; Kato, K; Sato, M; Yoshida, N; Ozawa, Y; Okada, K; Hidaka, M; Yuza, Y; Tanaka, M; Watanabe, K; Takita, J; Kosaka, Y; Fujita, N; Tanaka, J; Sato, A; Atsuta, Y; Imamura, T

    ANNALS OF HEMATOLOGY   Vol. 103 ( 3 ) page: 1015 - 1016   2024.3

     More details

  2. Dabrafenib and trametinib administration in patients with BRAF V600E/R or non-V600 BRAF mutated advanced solid tumours (BELIEVE, NCCH1901): a multicentre, open-label, and single-arm phase II trial.

    Shimoi T, Sunami K, Tahara M, Nishiwaki S, Tanaka S, Baba E, Kanai M, Kinoshita I, Shirota H, Hayashi H, Nishida N, Kubo T, Mamesaya N, Ando Y, Okita N, Shibata T, Nakamura K, Yamamoto N

    EClinicalMedicine   Vol. 69   page: 102447   2024.3

     More details

    Language:English  

    DOI: 10.1016/j.eclinm.2024.102447

    PubMed

  3. Utility of allogeneic stem cell transplantation for adult Ph plus ALL with complete molecular remission

    Nishiwaki, S; Sugiura, I; Fujisawa, S; Hatta, Y; Atsuta, Y; Doki, N; Kurahashi, S; Ueda, Y; Dobashi, N; Maeda, T; Matsumura, I; Tanaka, M; Kako, S; Ichinohe, T; Fukuda, T; Ohtake, S; Ishikawa, Y; Miyazaki, Y; Kiyoi, H

    AMERICAN JOURNAL OF HEMATOLOGY     2024.2

     More details

  4. Characteristics and prognosis of patients with COVID-19 and hematological diseases in Japan: a cross-sectional study

    Minakata, D; Uchida, T; Nakano, A; Takase, K; Tsukada, N; Kosugi, H; Kawata, E; Nakane, T; Takahashi, H; Endo, T; Nishiwaki, S; Fujiwara, H; Saito, AM; Saito, TI; Akashi, K; Matsumura, I; Mitani, K

    INTERNATIONAL JOURNAL OF HEMATOLOGY   Vol. 119 ( 2 ) page: 183 - 195   2024.2

     More details

  5. Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study

    Hirabayashi Shigeki, Kondo Tadakazu, Nishiwaki Satoshi, Mizuta Shuichi, Doki Noriko, Fukuda Takahiro, Uchida Naoyuki, Ozawa Yukiyasu, Kanda Yoshinobu, Imanaka Ryota, Takahashi Satoshi, Ishikawa Jun, Yano Shingo, Nakamae Hirohisa, Eto Tetsuya, Kimura Takafumi, Tanaka Junji, Ichinohe Tatsuo, Atsuta Yoshiko, Kako Shinichi

    AMERICAN JOURNAL OF HEMATOLOGY   Vol. 98 ( 10 ) page: 1606 - 1618   2023.7

     More details

  6. Phase II trial of dabrafenib and trametinib in patients with BRAFV600E/R or non-BRAFV600 mutated advanced solid tumors: Results from the BELIEVE trial (NCCH1901).

    Tahara, M; Shimoi, T; Nishiwaki, S; Tanaka, S; Baba, E; Muto, M; Kinoshita, I; Sakai, D; Tabata, M; Hayashi, H; Ishioka, C; Mamesaya, N; Yamamoto, N

    JOURNAL OF CLINICAL ONCOLOGY   Vol. 41 ( 16 )   2023.6

     More details

  7. High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph plus ALL TKI-SCT Study

    Nishiwaki Satoshi, Sugiura Isamu, Fujisawa Shin, Hatta Yoshihiro, Atsuta Yoshiko, Doki Noriko, Kurahashi Shingo, Ueda Yasunori, Dobashi Nobuaki, Maeda Tomoya, Taniguchi Yasuhiro, Tanaka Masatsugu, Kako Shinichi, Ichinohe Tatsuo, Fukuda Takahiro, Ohtake Shigeki, Ishikawa Yuichi, Kiyoi Hitoshi, Matsumura Itaru, Miyazaki Yasushi

    HEMASPHERE   Vol. 7 ( 6 ) page: e899   2023.6

     More details

  8. Autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia is safe but poses challenges for long-term maintenance of molecular remission: Results of the Auto-Ph17 study.

    Nishiwaki S, Sugiura I, Sato T, Kobayashi M, Osaki M, Sawa M, Adachi Y, Okabe M, Saito S, Morishita T, Kohno A, Nishiyama T, Iida H, Kurahashi S, Kuwatsuka Y, Sugiyama D, Ito S, Nishikawa H, Kiyoi H

    EJHaem   Vol. 4 ( 2 ) page: 358 - 369   2023.5

     More details

    Language:English  

    DOI: 10.1002/jha2.677

    PubMed

  9. Poor Prognostic Combination of Additional Chromosomal Abnormalities in Ph plus ALL : JALSG Ph plus ALL TKI- SCT Study

    Nishiwaki, S; Sugiura, I; Fujisawa, S; Hatta, Y; Doki, N; Kurahashi, S; Ueda, Y; Dobashi, N; Maeda, T; Taniguchi, Y; Tanaka, M; Kako, S; Ichinohe, T; Fukuda, T; Atsuta, Y; Ohtake, S; Ishikawa, Y; Kiyoi, H; Matsumura, I; Miyazaki, Y

    BLOOD   Vol. 140   page: 6030 - 6032   2022.11

  10. Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades

    Nishiwaki Satoshi, Akahoshi Yu, Morita-Fujita Mari, Shimizu Hiroaki, Uchida Naoyuki, Ozawa Yukiyasu, Fukuda Takahiro, Tanaka Masatsugu, Ikegame Kazuhiro, Ota Shuichi, Katayama Yuta, Takahashi Satoshi, Kawakita Toshiro, Ara Takahide, Onizuka Makoto, Kimura Takafumi, Tanaka Junji, Atsuta Yoshiko, Arai Yasuyuki

    BLOOD ADVANCES   Vol. 6 ( 15 ) page: 4558 - 4569   2022.8

     More details

  11. Dasatinib-based 2-step induction for adults with Philadelphia chromosome-positive acute lymphoblastic leukemia

    Sugiura Isamu, Doki Noriko, Hata Tomoko, Cho Ryuko, Ito Toshiro, Suehiro Youko, Tanaka Masatsugu, Kako Shinichi, Matsuda Mitsuhiro, Yokoyama Hisayuki, Ishikawa Yuichi, Taniguchi Yasuhiro, Hagihara Maki, Ozawa Yukiyasu, Ueda Yasunori, Hirano Daiki, Sakura Toru, Tsuji Masaaki, Kamae Tsuyoshi, Fujita Hiroyuki, Hiramoto Nobuhiro, Onoda Masahiro, Fujisawa Shin, Hatta Yoshihiro, Dobashi Nobuaki, Nishiwaki Satoshi, Atsuta Yoshiko, Kobayashi Yukio, Hayakawa Fumihiko, Ohtake Shigeki, Naoe Tomoki, Miyazaki Yasushi

    BLOOD ADVANCES   Vol. 6 ( 2 ) page: 624 - 636   2022.1

     More details

  12. COVID-19 Pandemic and Trends in Clinical Trials: A Multi-Region and Global Perspective

    Nishiwaki Satoshi, Ando Yuichi

    FRONTIERS IN MEDICINE   Vol. 8   page: 812370   2021.12

     More details

  13. The differential effect of disease status at allogeneic hematopoietic cell transplantation on outcomes in acute myeloid and lymphoblastic leukemia

    Yanada Masamitsu, Konuma Takaaki, Yamasaki Satoshi, Mizuno Shohei, Hirabayashi Shigeki, Nishiwaki Satoshi, Uchida Naoyuki, Doki Noriko, Tanaka Masatsugu, Ozawa Yukiyasu, Sawa Masashi, Eto Tetsuya, Kawakita Toshiro, Ota Shuichi, Fukuda Takahiro, Onizuka Makoto, Kimura Takafumi, Atsuta Yoshiko, Kako Shinichi, Yano Shingo

    ANNALS OF HEMATOLOGY   Vol. 100 ( 12 ) page: 3017 - 3027   2021.12

     More details

  14. Optimal treatment for Philadelphia-negative acute lymphoblastic leukemia in first remission in the era of high-intensity chemotherapy

    Kako Shinichi, Hayakawa Fumihiko, Imai Kiyotoshi, Tanaka Junji, Mizuta Shuichi, Nishiwaki Satoshi, Kanamori Heiwa, Mukae Junichi, Ozawa Yukiyasu, Kondo Tadakazu, Fukuda Takahiro, Ichinohe Tatsuo, Ota Shuichi, Tanaka Yoshinori, Murayama Tohru, Kurahashi Shingo, Sakura Toru, Usui Noriko, Ohtake Shigeki, Kiyoi Hitoshi, Matsumura Itaru, Miyazaki Yasushi, Atsuta Yoshiko

    INTERNATIONAL JOURNAL OF HEMATOLOGY   Vol. 114 ( 5 ) page: 608 - 619   2021.11

     More details

  15. Newly proposed threshold and validation of white blood cell count at diagnosis for Philadelphia chromosome-positive acute lymphoblastic leukemia: risk assessment of relapse in patients with negative minimal residual disease at transplantation-a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSTCT

    Akahoshi Yu, Arai Yasuyuki, Nishiwaki Satoshi, Tachibana Takayoshi, Shinohara Akihito, Doki Noriko, Uchida Naoyuki, Tanaka Masatsugu, Kanda Yoshinobu, Shiratori Souichi, Ozawa Yukiyasu, Shono Katsuhiro, Katayama Yuta, Tanaka Junji, Fukuda Takahiro, Atsuta Yoshiko, Kako Shinichi

    BONE MARROW TRANSPLANTATION   Vol. 56 ( 11 ) page: 2842 - 2848   2021.11

     More details

  16. Minimal residual disease (MRD) positivity at allogeneic hematopoietic cell transplantation, not the quantity of MRD, is a risk factor for relapse of Philadelphia chromosome-positive acute lymphoblastic leukemia

    Akahoshi Yu, Arai Yasuyuki, Nishiwaki Satoshi, Mizuta Shuichi, Marumo Atsushi, Uchida Naoyuki, Kanda Yoshinobu, Sakai Hitoshi, Takada Satoru, Fukuda Takahiro, Fujisawa Shin, Ashida Takashi, Tanaka Junji, Atsuta Yoshiko, Kako Shinichi

    INTERNATIONAL JOURNAL OF HEMATOLOGY   Vol. 113 ( 6 ) page: 832 - 839   2021.6

     More details

  17. Phase I clinical trial of intra-bone marrow cotransplantation of mesenchymal stem cells in cord blood transplantation

    Goto Tatsunori, Murata Makoto, Nishida Tetsuya, Terakura Seitaro, Kamoshita Sonoko, Ishikawa Yuichi, Ushijima Yoko, Adachi Yoshiya, Suzuki Satoshi, Kato Katsuyoshi, Hirakawa Akihiro, Nishiwaki Satoshi, Nishio Nobuhiro, Takahashi Yoshiyuki, Kodera Yoshihisa, Matsushita Tadashi, Kiyoi Hitoshi

    STEM CELLS TRANSLATIONAL MEDICINE   Vol. 10 ( 4 ) page: 542 - 553   2021.4

     More details

  18. Machine learning-aided risk stratification in Philadelphia chromosome-positive acute lymphoblastic leukemia

    Nishiwaki Satoshi, Sugiura Isamu, Koyama Daisuke, Ozawa Yukiyasu, Osaki Masahide, Ishikawa Yuichi, Kiyoi Hitoshi

    BIOMARKER RESEARCH   Vol. 9 ( 1 ) page: 13   2021.2

  19. Measurable residual disease affects allogeneic hematopoietic cell transplantation in Ph+ ALL during both CR1 and CR2

    Nishiwaki Satoshi, Akahoshi Yu, Mizuta Shuichi, Shinohara Akihito, Hirabayashi Shigeki, Noguchi Yuma, Fukuda Takahiro, Uchida Naoyuki, Tanaka Masatsugu, Onizuka Makoto, Ozawa Yukiyasu, Ota Shuichi, Shiratori Souichi, Onishi Yasushi, Kanda Yoshinobu, Sawa Masashi, Tanaka Junji, Atsuta Yoshiko, Kako Shinichi

    BLOOD ADVANCES   Vol. 5 ( 2 ) page: 584 - 592   2021.1

     More details

  20. In vivo tracking of transplanted macrophages with near infrared fluorescent dye reveals temporal distribution and specific homing in the liver that can be perturbed by clodronate liposomes

    Nishiwaki Satoshi, Saito Shigeki, Takeshita Kyosuke, Kato Hidefumi, Ueda Ryuzo, Takami Akiyoshi, Naoe Tomoki, Ogawa Mika, Nakayama Takayuki

    PLOS ONE   Vol. 15 ( 12 ) page: e0242488   2020.12

     More details

  21. Multi-Lineage BCR-ABL Expression in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Associated With Improved Prognosis but No Specific Molecular Features

    Nishiwaki Satoshi, Kim Jeong Hui, Ito Masafumi, Maeda Matsuyoshi, Okuno Yusuke, Koyama Daisuke, Ozawa Yukiyasu, Gunji Masaharu, Osaki Masahide, Kitamura Kunio, Ushijima Yoko, Ishikawa Yuichi, Miyamura Koichi, Sugiura Isamu, Kiyoi Hitoshi

    FRONTIERS IN ONCOLOGY   Vol. 10   page: 586567   2020.10

     More details

  22. Gap between pediatric and adult approvals of molecular targeted drugs

    Nishiwaki Satoshi, Ando Yuichi

    SCIENTIFIC REPORTS   Vol. 10 ( 1 ) page: 17145   2020.10

     More details

  23. Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leukemia Working Group of the JSHCT

    Akahoshi Yu, Nishiwaki Satoshi, Arai Yasuyuki, Harada Kaito, Najima Yuho, Kanda Yoshinobu, Shono Katsuhiro, Ota Shuichi, Fukuda Takahiro, Uchida Naoyuki, Shiratori Souichi, Tanaka Masatsugu, Tanaka Junji, Atsuta Yoshiko, Kako Shinichi

    BONE MARROW TRANSPLANTATION   Vol. 55 ( 7 ) page: 1317 - 1325   2020.7

     More details

  24. A consideration for efficient unrelated hematopoietic stem cell source acquisition-from an experience of Japan

    Nishiwaki Satoshi, Miyamura Koichi, Kanda Yoshinobu, Takanashi Minoko, Uchida Naoyuki, Fukuda Takahiro, Ikegame Kazuhiro, Ohashi Kazuteru, Eto Tetsuya, Ozawa Yukiyasu, Shiratori Souichi, Iwato Koji, Matsuoka Ken-ichi, Hidaka Michihiro, Ichinohe Tatsuo, Atsuta Yoshiko, Kodera Yoshihisa, Okamoto Shinichiro

    BONE MARROW TRANSPLANTATION   Vol. 55 ( 3 ) page: 657 - 660   2020.3

     More details

  25. Myeloablative Vs Reduced-Intensity Conditioning for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Among Patients over 50 Years Old Who Achieved Negative Minimal Residual Disease

    Akahoshi Yu, Nishiwaki Satoshi, Arai Yasuyuki, Harada Kaito, Doki Noriko, Kanda Yoshinobu, Shono Katsuhiro, Ohta Shuichi, Fukuda Takahiro, Uchida Naoyuki, Tanakaw Junji, Atsuta Yoshiko, Kako Shinichi

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   Vol. 26 ( 3 ) page: S162 - S163   2020.3

     More details

    Language:Japanese  

    Web of Science

  26. Phase I Study of Cord Blood Transplantation with Intra-Bone Marrow Injection of Mesenchymal Stem Cells

    Goto Tatsunori, Murata Makoto, Nishida Tetsuya, Terakura Seitaro, Kamoshita Sonoko, Ishikawa Yuichi, Ushijima Yoko, Adachi Yoshiya, Kato Katsuyoshi, Hirakawa Akihiro, Nishiwaki Satoshi, Nishio Nobuhiro, Takahashi Yoshiyuki, Kodera Yoshihisa, Matsushita Tadashi, Kiyoi Hitoshi

    BLOOD   Vol. 134   2019.11

     More details

    Language:Japanese  

    DOI: 10.1182/blood-2019-122101

    Web of Science

  27. Dasatinib-Based Two-Step Induction Prior to Allogeneic Hematopoietic Cell Transplantation for Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Results of the JALSG Ph+ALL213 Study

    Sugiura Isamu, Doki Noriko, Hata Tomoko, Cho Ryuko, Ito Toshiro, Suehiro Youko, Kanamori Heiwa, Kako Shinichi, Matsuda Mitsuhiro, Yokoyama Hisayuki, Taniguchi Yasuhiro, Hagihara Maki, Ozawa Yukiyasu, Fujisawa Shin, Dobashi Nobuaki, Hatta Yoshihiro, Asada Noboru, Ohashi Kazuteru, Onishi Yasushi, Shiro Koh, Nishiwaki Satoshi, Atsuta Yoshiko, Hayakawa Fumihiko, Ohtake Shigeki, Miyazaki Yasushi

    BLOOD   Vol. 134   2019.11

     More details

    Language:Japanese  

    DOI: 10.1182/blood-2019-123382

    Web of Science

  28. The Optimal Treatment Strategy for Adult Patients with Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia in First Complete Remission in the Era of High-Intensity Chemotherapy

    Kako Shinichi, Hayakawa Fumihiko, Imai Kiyotoshi, Tanaka Junji, Mizuta Shuichi, Nishiwaki Satoshi, Kanamori Heiwa, Doki Noriko, Uchida Naoyuki, Ikegame Kazuhiro, Fukuda Takahiro, Ichinohe Tatsuo, Ota Shuichi, Tanaka Yoshinori, Murayama Tohru, Kurahashi Shingo, Sakura Toru, Usui Noriko, Ohtake Shigeki, Kiyoi Hitoshi, Matsumura Itaru, Miyazaki Yasushi, Atsuta Yoshiko

    BLOOD   Vol. 134   2019.11

     More details

    Language:Japanese  

    DOI: 10.1182/blood-2019-126012

    Web of Science

  29. Application of the New Process for Unapproved Drug Use: Dilemma of Universal Health Care Coverage in Japan

    Nishiwaki Satoshi, Ando Yuichi

    JOURNAL OF GLOBAL ONCOLOGY   Vol. 5   page: 1 - 3   2019.11

     More details

  30. Different impact of BCR-ABL transcripts on allogeneic hematopoietic cell transplantation from different graft sources for Ph plus ALL with minimal residual disease

    Nishiwaki Satoshi, Mizuta Shuichi, Ohashi Kazuteru, Fukuda Takahiro, Uchida Naoyuki, Tachibana Takayoshi, Onizuka Makoto, Ozawa Yukiyasu, Onishi Yasushi, Takahashi Satoshi, Eto Tetsuya, Nakamae Hirohisa, Tanaka Junji, Ichinohe Tatsuo, Atsuta Yoshiko, Kako Shinichi

    AMERICAN JOURNAL OF HEMATOLOGY   Vol. 94 ( 11 ) page: E301 - E305   2019.11

     More details

  31. Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia

    Akahoshi Yu, Nishiwaki Satoshi, Mizuta Shuichi, Ohashi Kazuteru, Uchida Naoyuki, Tanaka Masatsugu, Fukuda Takahiro, Ozawa Yukiyasu, Takahashi Satoshi, Onizuka Makoto, Shiratori Souichi, Nakamae Hirohisa, Kanda Yoshinobu, Ichinohe Tatsuo, Atsuta Yoshiko, Kako Shinichi

    CANCER SCIENCE   Vol. 110 ( 10 ) page: 3255 - 3266   2019.10

     More details

  32. Allogeneic Stem Cell Transplantation for Acute Lymphoblastic Leukemia in Adolescents and Young Adults

    Hangai Mayumi, Urayama Kevin Y., Tanaka Junji, Kato Koji, Nishiwaki Satoshi, Koh Katsuyoshi, Noguchi Maiko, Kato Keisuke, Yoshida Nao, Sato Maho, Goto Hiroaki, Yuza Yuki, Hashii Yoshiko, Atsuta Yoshiko, Mizuta Shuichi, Kato Motohiro

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   Vol. 25 ( 8 ) page: 1597 - 1602   2019.8

     More details

  33. Prophylactic Use of Tyrosine Kinase Inhibitors in Patients with Negative Results for Minimal Residual Disease after Allogeneic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

    Akahoshi Yu, Nishiwaki Satoshi, Mizuta Shuichi, Ohashi Kazuteru, Uchida Naoyuki, Kanamori Heiwa, Fukuda Takahiro, Ozawa Yukiyasu, Kanda Yoshinobu, Ichinohe Tatsuo, Atsuta Yoshiko, Kako Shinichi

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION   Vol. 25 ( 3 )   2019.3

     More details

    Language:Japanese  

    Web of Science

  34. Availability of HLA-allele-matched unrelated donors: estimation from haplotype frequency in the Japanese population.

    Nishiwaki S, Tanaka H, Kojima H, Okamoto S

    Bone marrow transplantation   Vol. 54 ( 2 ) page: 300 - 303   2019.2

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.1038/s41409-018-0263-9

    Web of Science

    PubMed

  35. Optimal Interval for Detection of Molecular Relapse after Stop of TKI in Ph plus ALL Calculating By M Kinetics

    Miyamura Koichi, Nishiwaki Satoshi

    BLOOD   Vol. 132   2018.11

     More details

  36. Outcomes of strategic alternative donor selection or suspending donor search based on Japan Marrow Donor Program coordination status

    Kawashima Naomi, Nishiwaki Satoshi, Shimizu Naoko, Kamoshita Sonoko, Watakabe Kyoko, Yokohata Emi, Kurahashi Shingo, Ozawa Yukiyasu, Miyamura Koichi

    INTERNATIONAL JOURNAL OF HEMATOLOGY   Vol. 107 ( 5 ) page: 551 - 558   2018.5

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s12185-018-2413-7

    Web of Science

    PubMed

  37. Phase I study of cord blood transplantation with intrabone marrow injection of mesenchymal stem cells: A clinical study protocol

    Goto Tatsunori, Murata Makoto, Terakura Seitaro, Nishida Tetsuya, Adachi Yoshiya, Ushijima Yoko, Shimada Kazuyuki, Ishikawa Yuichi, Hayakawa Fumihiko, Nishio Nobuhiro, Nishiwaki Satoshi, Hirakawa Akihiro, Kato Katsuyoshi, Takahashi Yoshiyuki, Kiyoi Hitoshi

    MEDICINE   Vol. 97 ( 17 ) page: e0449   2018.4

     More details

  38. Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study) Reviewed

    Nishiwaki S, Sugiura I, Miyata Y, Saito S, Sawa M, Nishida T, Miyamura K, Kuwatsuka Y, Kohno A, Yuge M, Kasai M, Iida H, Kurahashi S, Osaki M, Goto T, Terakura S, Murata M, Nishikawa H, Kiyoi H

    Medicine   Vol. 96 ( 52 ) page: e9568   2017.12

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  39. Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia: A case report and literature review Reviewed

    Harada Y, Nishiwaki S, Sugimoto T, Onodera K, Goto T, Sato T, Kamoshita S, Kawashima N, Seto A, Okuno S, Yamamoto S, Iwasaki T, Ozawa Y, Miyamura K, Akatsuka Y, Sugiura I

    Medicine   Vol. 96 ( 50 ) page: e9160   2017.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  40. Impact of Synchronous Multiple Primary Malignant Tumors on Newly Diagnosed Hematological Malignancies Reviewed

    Nishiwaki S, Okuno S, Suzuki K, Kurahashi S, Sugiura I

    Clinical Lymphoma, Myeloma & Leukemia   Vol. 17 ( 12 ) page: E79 - E85   2017.12

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    DOI: 10.1016/j.clml.2017.09.006

    Web of Science

    PubMed

  41. Efficacy and safety of autologous peripheral blood stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia: A study protocol for a multicenter exploratory prospective study (Auto-Ph17 study)

    Nishiwaki Satoshi, Sugiura Isamu, Miyata Yasuhiko, Saito Shigeki, Sawa Masashi, Nishida Tetsuya, Miyamura Koichi, Kuwatsuka Yachiyo, Kohno Akio, Yuge Masaaki, Kasai Masanobu, Iida Hiroatsu, Kurahashi Shingo, Osaki Masahide, Goto Tatsunori, Terakura Seitaro, Murata Makoto, Nishikawa Hiroyoshi, Kiyoi Hitoshi

    MEDICINE   Vol. 96 ( 52 ) page: e9568   2017.12

     More details

  42. Successful treatment with allogeneic stem cell transplantation followed by DLI and TKIs for e6a2 BCR-ABL-positive acute myeloid leukaemia A case report and literature review

    Harada Yasuhiko, Nishiwaki Satoshi, Sugimoto Takumi, Onodera Koichi, Goto Tatsunori, Sato Takahiko, Kamoshita Sonoko, Kawashima Naomi, Seto Aika, Okuno Shingo, Yamamoto Satomi, Iwasaki Toshihiro, Ozawa Yukiyasu, Miyamura Koichi, Akatsuka Yoshiki, Sugiura Isamu

    MEDICINE   Vol. 96 ( 50 ) page: e9160   2017.12

     More details

  43. Prognostic impact of synchronous multiple primary malignant tumors on newly diagnosed hematological malignancies

    Nishiwaki S., Okuno S., Suzuki K., Kurahashi S., Sugiura I.

    ANNALS OF ONCOLOGY   Vol. 28   2017.11

     More details

    Language:Japanese  

    Web of Science

  44. Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study.

    Koyama D, Nishiwaki S, Harada Y, Yamamoto S, Kurahashi S, Sugimoto T, Iwasaki T, Sugiura I

    Japanese journal of clinical oncology   Vol. 47 ( 9 ) page: 820 - 825   2017.9

     More details

    Language:English  

    DOI: 10.1093/jjco/hyx076

    PubMed

  45. Effective chemomobilization with etoposide and cytarabine (EC regimen) in lymphoma patients: a single-center, retrospective, observational study Reviewed

    Koyama D, Nishiwaki S, Harada Y, Yamamoto S, Kurahashi S, Sugimoto T, Iwasaki T, Sugiura I

    Japanese Journal of Clinical Oncology   Vol. 47 ( 9 ) page: 820-825   2017.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  46. Increase of bone marrow macrophages and CD8(+) T lymphocytes predict graft failure after allogeneic bone marrow or cord blood transplantation

    Kawashima N., Terakura S., Nishiwaki S., Koyama D., Ozawa Y., Ito M., Miyamura K.

    BONE MARROW TRANSPLANTATION   Vol. 52 ( 8 ) page: 1164 - 1170   2017.8

  47. PROGNOSTIC IMPACT OF SYNCHRONOUS MULTIPLE PRIMARY MALIGNANT TUMORS ON NEWLY DIAGNOSED LYMPHOMA PATIENTS

    Nishiwaki S., Okuno S., Suzuki K., Kurahashi S., Sugiura I.

    HAEMATOLOGICA   Vol. 102   page: 700 - 700   2017.6

     More details

    Language:Japanese  

    Web of Science

  48. Clinical efficacy of fecal occult blood test and colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients

    Nishiwaki Satoshi, Maeda Matsuyoshi, Yamada Masahiro, Okuno Shingo, Harada Yasuhiko, Suzuki Kotaro, Kurahashi Shingo, Urano Fumihiro, Okamura Shozo, Sugiura Isamu

    BLOOD   Vol. 129 ( 1 ) page: 126 - 128   2017.1

     More details

  49. Clinical efficacy of fecal occult blood test followed by colonoscopy for dasatinib-induced hemorrhagic colitis in CML patients Reviewed

    Nishiwaki S, Maeda M, Yamada M, Okuno S, Harada Y, Suzuki K, Kurahashi S, Urano F, Okamura S, Sugiura I

    Blood   Vol. 129 ( 1 ) page: 126-128   2017.1

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  50. A new prognostic index to make short-term prognosis in MDS patients treated with azacitidine; a combination of p53 expression and cytogenetics Reviewed

    Nishiwaki S, Ito M, Watarai R, Okuno S, Harada Y, Yamamoto S, Suzuki K, Kurahashi S, Iwasaki T, Sugiura I

    Leukemia Research   Vol. 41   page: 21-6   2016

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  51. Impact of MRD and TKI on allogeneic hematopoietic cell transplantation for Ph+ALL: a study from the Adult ALL WG of the JSHCT Reviewed

    Nishiwaki S, Imai K, Mizuta S, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Takahashi S, Uchida N, Eto T, Nakamae H, Yujiri T, Mori S, Nagamura-Inoue T, Suzuki R, Atsuta Y, Tanaka J

    Bone Marrow Transplant   Vol. 51 ( 1 ) page: 43-55   2016

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  52. Cervical epidural hematoma in a healthy donor presenting stroke mimic symptoms: a rare adverse event following peripheral blood stem cell apheresis Reviewed

    Terabe S, Nishiwaki S, Koyama D, Okuno S, Harada Y, Tomita H, Yoshihara H, Iwasaki T, Sugiura I

    Japanese Journal of Clinical Oncology   Vol. 45 ( 6 ) page: 584-7   2015

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  53. Roles of volunteers and professionals in medical development -insights from the development of Allo-HSCT Reviewed

    Nishiwaki S

    Japanese Journal of Clinical Oncology   Vol. 45 ( 5 ) page: 502-3   2015

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  54. Pros and Cons of Legislation on Allogeneic Hematopoietic Stem Cell Transplantation Reviewed

    Nishiwaki S

    Japanese Journal of Clinical Oncology   Vol. 45 ( 3 ) page: 311-2   2015

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  55. Rules of providing cord blood for iPS cells for research Reviewed

    Nishiwaki S

    Cytotherapy   Vol. 17 ( 7 ) page: 1008   2015

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  56. Provision of human immunodeficiency virus infection following cord blood transplantation Reviewed

    Nishiwaki S

    British Journal of Haematology   Vol. 166 ( 6 ) page: 956-7   2014

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  57. Pretransplant administration of imatinib for allo-HSCT in patients with BCR-ABL-positive acute lymphoblastic leukemia Reviewed

    Mizuta S, Matsuo K, Nishiwaki S, Imai K, Kanamori H, Ohashi K, Fukuda T, Onishi Y, Miyamura K, Takahashi S, Onizuka M, Atsuta Y, Suzuki R, Morishima Y, Kato K, Sakamaki H, Tanaka J

    Blood   Vol. 123 ( 15 ) page: 2325-32   2014

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

  58. Complete nationwide survey on umbilical cord blood freezing bag breakage in Japan Reviewed

    Nishiwaki S, Izumi J

    Cytotherapy   Vol. 16 ( 11 ) page: 1590-4   2014

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  59. Dexamethasone palmitate ameliorates macrophages-rich graft-versus-host disease by inhibiting macrophage functions Reviewed

    Nishiwaki S, Nakayama T, Murata M, Nishida T, Terakura S, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Miyamura K, Ito M, Takeshita K, Kato H, Toyokuni D, Nagao K, Ueda R, Naoe T

    PLoS One   Vol. 9 ( 5 ) page: e96252   2014

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  60. Impact of donor source on adult Philadelphia chromosome-negative acute lymphoblastic leukemia: a retrospective analysis from the Adult Acute Lymphoblastic Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation Reviewed

    Nishiwaki S, Miyamura K, Ohashi K, Kurokawa M, Taniguchi S, Fukuda T, Ikegame K, Takahashi S, Mori T, Imai K, Iida H, Hidaka M, Sakamaki H, Morisima Y, Kato K, Suzuki R, Tanaka J

    Annals of Oncology   Vol. 24 ( 6 ) page: 1594-602   2013

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  61. Allogeneic hematopoietic cell transplantation from alternative sources for adult Philadelphia chromosome-negative acute lymphoblastic leukemia: What should we choose when no HLA-matched related donor is available? Invited Reviewed

    Nishiwaki S, Atsuta Y, Tanaka J

    Bone Marrow Transplantation   Vol. 48 ( 11 ) page: 1369-76   2013

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  62. Allogeneic stem cell transplant for adult Philadelphia chromosome-negative acute lymphoblastic leukemia Reviewed

    Nishiwaki S, Miyamura K

    Leukemia & Lymphoma   Vol. 53 ( 4 ) page: 550-6   2012

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  63. Efficacy and safety of human adipose tissue-derived mesenchymal stem cells for supporting hematopoiesis Reviewed

    Nishiwaki S, Nakayama T, Saito S, Mizuno H, Ozaki T, Takahashi Y, Maruyama S, Nishida T, Murata M, Kojima S,Naoe T

    International Journal of Hematology   Vol. 96 ( 3 ) page: 295-300   2012

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  64. Dexamethasone palmitate successfully attenuates hemophagocytic syndrome after allogeneic stem cell transplantation: macrophage-targeted steroid therapy Reviewed

    Nishiwaki S, Nakayama T, Murata M, Nishida T, Sugimoto K, Saito S, Kato T, Mizuno H, Imahashi N, Seto A, Ozawa Y, Goto T, Koyama D, Yokohata E, Kubota N, Kamoshita S, Miyamura K, Matsumoto K, Ito M, Naoe T

    International Journal of Hematology   Vol. 95 ( 4 ) page: 428-33   2012

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  65. Reduced-intensity versus conventional myeloablative conditioning for patients with Philadelphia chromosome-negative acute lymphoblastic leukemia in complete remission Reviewed

    Nishiwaki S, Inamoto Y, Imamura M, Tsurumi H, Hatanaka K, Kawa K, Suzuki R, Miyamura K

    Blood   Vol. 117 ( 13 ) page: 3698-9   2011

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  66. Allogeneic stem cell transplantation for adult Philadelphia chromosome-negative acute lymphocytic leukemia: comparable survival rates but different risk factors between related and unrelated transplantation in first complete remission Reviewed

    Nishiwaki S, Inamoto Y, Sakamaki H, Kurokawa M, Iida H, Ogawa H, Fukuda T, Ozawa Y, Kobayashi N, Kasai M, Mori T, Iwato K, Yoshida T, Onizuka M, Kawa K, Morisima Y, Suzuki R, Atsuta Y, Miyamura K

    Blood   Vol. 116 ( 20 ) page: 4368-75   2010

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  67. Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission Reviewed

    Nishiwaki S, Terakura S, Yasuda T, Imahashi N, Sao H, Iida H, Kamiya Y, Niimi K, Morishita Y, Kohno A, Yokozawa T, Ohashi H, Sawa M, Kodera Y, Miyamura K

    International Journal of Hematology   Vol. 91 ( 3 ) page: 419-25   2010

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  68. Impact of Post-transplant Imatinib Administration on Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia Reviewed

    Nishiwaki S, Miyamura K, Kato C, Terakura S, Ohashi K, Sakamaki H, Nakao S, Harigae H, Kodera Y

    Anticancer Research   Vol. 30 ( 6 ) page: 2415-8   2010

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  69. Impact of macrophage infiltration of skin lesions on survival after allogeneic stem cell transplantation: a clue to refractory graft-versus-host disease Reviewed

    Nishiwaki S, Terakura S, Ito, M, Goto T, Seto A, Watanabe K, Yanagisawa M, Imanashi N, Tsukamoto S, Shimba M, Ozawa Y, Miyamura K

    Blood   Vol. 114 ( 14 ) page: 3113-6   2009

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

  70. Impact of the basal metabolic ratio in predicting early deaths after allogeneic stem cell transplantation Reviewed

    Nishiwaki S, Miyamura K, Seto A, Watanabe K, Yanagisawa M, Imahashi N, Shimba M, Yasuda T, Kuwatsuka Y, Oba T, Terakura S, Kodera Y

    American Journal of Hematology   Vol. 84 ( 9 ) page: 608-11   2009

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

▼display all

Books 8

  1. EBM 血液疾患の治療<2019-2020>

    西脇 聡史( Role: Contributor ,  ステロイド抵抗性急性GVHDに対する救援療法)

    中外医学者  2018.10 

     More details

    Total pages:567   Language:Japanese Book type:Scholarly book

  2. 日本臨床 増刊号 白血病学(下)・急性GVHDにおける皮膚マクロファージ浸潤の臨床的意義 

    西脇聡史( Role: Sole author)

    日本臨床社  2016 

     More details

    Language:Japanese Book type:Scholarly book

  3. 日本臨床 増刊号 白血病学(上)・PCRによるMRDの検出

    宮村耕一, 西脇聡史( Role: Joint author)

    日本臨床社  2016 

     More details

    Language:Japanese Book type:Scholarly book

  4. 血液内科・急性リンパ性白血病の分子病態

    西脇聡史( Role: Sole author)

    科学評論社  2014.2 

     More details

    Language:Japanese Book type:Scholarly book

  5. 分子標的薬マスターガイド・血液 白血病 臓器別分子標的薬の位置づけ

    西脇聡史, 直江知樹( Role: Joint author)

    中外医学社  2014.7 

     More details

    Language:Japanese Book type:Scholarly book

  6. 血液内科・成人フィラデルフィア染色体陰性急性リンパ性白血病に対する同種造血幹細胞移植

    西脇聡史( Role: Sole author)

    科学評論社  2011 

     More details

    Language:Japanese Book type:Scholarly book

  7. 血液・腫瘍科・皮膚GVHDにおけるマクロファージ浸潤の臨床的意義:治療抵抗性GVHDの手がかりとなるか?

    西脇聡史, 伊藤雅文( Role: Joint author)

    科学評論社  2010 

     More details

    Language:Japanese Book type:Scholarly book

  8. 内科・微小残存病変の定量 -治療の道しるべとなるか?-

    西脇聡史, 宮村耕一( Role: Joint author)

    南江堂  2007 

     More details

    Language:Japanese Book type:Scholarly book

▼display all

Presentations 8

  1. Notes on efficient donor recruitment: estimation from haplotype frequency in the Japanese population International conference

    Satoshi Nishiwaki, Hidenori Tanaka, Hiroto, Kojima, Shinichiro Okamoto

    12th International Donor Registry Conference  

     More details

    Event date: 2018.6

    Language:English   Presentation type:Poster presentation  

    Country:Germany  

  2. Prognostic impact of synchronous multiple primary malignant tumors on newly diagnosed hematological malignancies International conference

    Nishiwaki S, Okuno S, Suzuki K, Kurahashi S, Sugiura I

    ESMO Asia 2017 

     More details

    Event date: 2017.11

    Language:English   Presentation type:Poster presentation  

    Venue:Singapore   Country:Singapore  

  3. Medical treatment system based on patient's request in Nagoya Univ Hospital-Experience of Auto-PBSCT using Thiotepa-

    Nishiwaki S

     More details

    Event date: 2017.7

    Language:Japanese   Presentation type:Symposium, workshop panel (nominated)  

    Country:Japan  

  4. Significance of Fecal Occult Blood Test Followed by Colonoscopy for Asymptomatic Dasatinib-induced Hemorrhagic Colitis (CML1501 Study) International conference

    Nishiwaki S, Maeda M, Yamada M, Okuno S, Harada Y, Suzuki K, Kurahashi S, Urano F, Okamura S, Sugiura I

    58th Annual Meeting of American Society of Hematology 

     More details

    Event date: 2016.12

    Language:English   Presentation type:Poster presentation  

    Venue:San Diego   Country:United States  

  5. Minimal residual disease-based strategies in hematopoietic cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia Invited International conference

    Nishiwaki S

    20th Winter Meeting of the KSBMT 

     More details

    Event date: 2016.2

    Language:English   Presentation type:Oral presentation (invited, special)  

    Venue:Pyeongchang-gun   Country:Korea, Republic of  

  6. A new prognostic index to predict short-term prognosis in MDS patients treated with azacitidine; combination of p53 expression and cytogenetics International conference

    Nishiwaki S, Ito M, Okuno S, Harada Y, Yamamoto S, Iwasaki T, Sugiura I

    20th Congress of the European Hematology Association 

     More details

    Event date: 2015.6

    Language:English   Presentation type:Poster presentation  

    Venue:Vienna   Country:Austria  

  7. ダサチニブによる無症候性出血性腸炎に対する便潜血検査と下部消化管内視鏡検査の有用性

    西脇聡史, 前多松喜, 山田雅弘, 奥野真吾, 原田靖彦, 鈴木弘太郎, 倉橋信悟, 浦野文博, 岡村正造, 杉浦勇

    第78回日本血液学会 総会 

     More details

    Event date: 2016.10

    Language:Japanese   Presentation type:Oral presentation (general)  

    Venue:横浜2016・   Country:Japan  

  8. Ph(+)ALLにおけるMRDと移植成績 Invited

    西脇聡史, 宮村耕一

    第38回日本造血細胞移植学会総会 

     More details

    Event date: 2016.3

    Language:Japanese   Presentation type:Oral presentation (invited, special)  

    Venue:名古屋   Country:Japan  

▼display all

KAKENHI (Grants-in-Aid for Scientific Research) 2

  1. Multilateral prognostic factor analysis for Ph+ALL in the era of TKI

    Grant number:20K08730  2020.4 - 2023.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Scientific Research (C)

      More details

    Authorship:Principal investigator 

    Grant amount:\4420000 ( Direct Cost: \3400000 、 Indirect Cost:\1020000 )

  2. Significance of BCR gene breakpoint in Ph + ALL

    Grant number:17K16186  2017.4 - 2021.3

    Grants-in-Aid for Scientific Research  Grant-in-Aid for Young Scientists (B)

    NISHIWAKI Satoshi

      More details

    Authorship:Principal investigator 

    Grant amount:\4030000 ( Direct Cost: \3100000 、 Indirect Cost:\930000 )

    Multi-lineage BCR-ABL expression (Multi-Ph) was defined in 21 of 59 patients (36%). BCR breakpoint was major in 17 of 21 Multi-Ph (81%). In such patients, BCR-ABL was detected at the multipotent progenitor level. However, no IKZF1 deletion patterns that were specific for Multi-Ph were identified. On the other hand, better survival rates were observed in patients with Multi-Ph compared with survival rates in those with uni-lineage BCR-ABL expression. In multivariate analyses, Multi-Ph was identified as a good prognostic factor for both overall survival and event-free survival. We confirmed Multi-Ph in more than one-third of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia. Although no specific molecular characteristics were identified, Multi-Ph was associated with better treatment outcomes.